Displaying 241 - 260 of 1097
PIP Number | Active Substance | Conditions / Indications | Invented Name | Therapeutic area | Decision Type | Compliance Check | Compliance outcome | Date Published Sort ascending |
---|---|---|---|---|---|---|---|---|
PIP Number MHRA-100823-PIP01-22-M02 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-101359-PIP01-24 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-101021-PIP01-23-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100273-PIP03-24 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-101342-PIP01-24-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-101379-PIP01-24 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-101385-PIP01-24 | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type W: decision granting a waiver in all age groups for the listed condition(s). | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100543-PIP01-22-M03 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-101073-PIP01-23-M02 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type W: decision granting a waiver in all age groups for the listed condition(s). | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-101004-PIP01-23-M02 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-101123-PIP01-23-M02 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100523-PIP01-22-M03 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100524-PIP01-22-M03 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100566-PIP01-22-M03 (update) | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100093-PIP01-21-M04 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100382-PIP01-21-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100934-PIP01-23-M02 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-101302-PIP01-23-M01 (update) | Active Substance
|
Conditions / Indications
|
Invented Name
|
Therapeutic area
|
Decision Type PM: decision on the application for modification of an agreed paediatric investigation plan. | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-101098-PIP01-23 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |
PIP Number MHRA-100851-PIP01-23 | Active Substance
|
Conditions / Indications
|
Invented Name | Therapeutic area
|
Decision Type P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s) | Compliance Check No | Compliance outcome | Date Published Sort ascending |